Archived Newsletters

71. 05.06.25 -- Cutting Costs In Cell & Gene Therapy? Read This First. 5/6/2025
    05/06/25 Outsourced Pharma Newsletter
72. 05.05.25 -- Meeting The Demand For Cell & Gene Therapy Commercialization 5/5/2025
    05/05/25 Outsourced Pharma Newsletter
73. 05.05.25 -- STREAM Edition: The BIOSECURE Act Will Be Back… With A Dose Of Tariffs! 5/5/2025

    05/05/25 Outsourced Pharma Newsletter

74. 05.05.25 -- From Lab To Launch: Smarter Strategies, Faster Trials, And Future Technologies 5/5/2025
    05/05/25 Outsourced Pharma Newsletter
75. 05.02.25 -- Meeting The Demand For Bioanalytical Services 5/2/2025
    05/02/25 Outsourced Pharma Newsletter
76. 05.02.25 -- Tariffs Rising, But R&D Licensing From China Keeps Climbing 5/2/2025
    05/02/25 Outsourced Pharma Newsletter
77. 05.01.25 -- New Podcast Episodes: China's Growth, Investment Trends, NIH Cuts, and more 5/1/2025
    05/01/25 Outsourced Pharma Newsletter
78. 05.01.25 -- Biopharma Under Pressure: Tariff Strategies, Hiring Trends, Logistic Solutions 5/1/2025
    05/01/25 Outsourced Pharma Newsletter
79. 04.30.25 -- Outsourced BDs On The Rise; Strategies For Smarter Pharma Development 4/30/2025
    04/30/25 Outsourced Pharma Newsletter
80. 04.29.25 -- Biotech Hiring Heats Up; Advances In Cell & Gene Therapy 4/29/2025
    04/29/25 Outsourced Pharma Newsletter